Fig. 1From: Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case reportRepresentative computed tomographic images demonstrating treatment efficacy. Lesions in lung and under liver are presented at baseline and after 8 and 18 weeks of treatment with a combination of BRAF and MEK inhibitorsBack to article page